In a small case series of hemophilia A patients with overlapping RA or psoriatic arthritis, systemic anti-TNF-α therapy with adalimumab proved to be useful not only in controlling synovitis and inducing disease remission but also in reducing joint bleeding [35]. The gene discussed is TNF; the disease is rheumatoid arthritis.